BCTX
BriaCell Therapeutics Corp · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website briacell.com
- Employees(FY) 16
- ISIN CA1079301091
Performance
+18.18%
1W
-21.76%
1M
-50.29%
3M
-66.99%
6M
-71.11%
YTD
-71.22%
1Y
Profile
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Technical Analysis of BCTX 2024-05-31
Overview:
In analyzing the technical indicators for BCTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...
Recent News & Updates
- 2022-12-01 21:00
- 2022-11-29 19:04
- 2022-11-20 16:10
BCTX: SITC Poster Presentation(Yahoo Finance)
- 2022-11-14 19:00
- 2022-11-09 20:00
- 2022-10-30 19:54
BCTX: Fiscal Year 2022 Results(Yahoo Finance)
- 2022-10-20 21:00
- 2022-10-13 19:13
- 2022-10-11 21:00
- 2022-09-27 21:15
- 2022-09-13 21:20
- 2022-09-06 21:25
- 2022-08-16 22:13
- 2022-08-05 02:41
- 2022-08-03 21:00
- 2022-07-20 20:23
- 2022-07-04 21:00
- 2022-06-28 21:00
- 2022-06-23 21:00
- 2022-06-22 19:40
BCTX: New Sites Expand Bria-IMT Trial(Yahoo Finance)
- 2022-05-17 21:15
- 2022-05-06 03:02
- 2022-04-12 20:00
- 2022-04-12 04:30
- 2022-04-06 20:30
- 2022-03-28 17:44
BCTX: Second Quarter Results(Yahoo Finance)
- 2022-02-27 19:00
- 2022-02-22 19:00
- 2022-02-15 19:00
- 2022-02-10 15:12